News from ginkgo bioworks A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 25, 2023, 07:00 ET Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and anti-fungals, ...

May 10, 2023, 16:01 ET Ginkgo Bioworks Reports First Quarter 2023 Financial Results

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...

May 09, 2023, 07:00 ET Octarine Bio and Ginkgo Bioworks Announce Partnership to Produce Natural Colors

Octarine Bio, a synthetic biology company developing new sustainable bio-based ingredients, and Ginkgo Bioworks (NYSE: DNA), which is building the...

May 08, 2023, 07:00 ET Ginkgo Bioworks Partners with Boehringer Ingelheim to Develop Breakthrough Therapies for Hard-to-Treat Diseases

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership with...

May 05, 2023, 07:00 ET Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity,...

May 04, 2023, 07:00 ET Ginkgo Bioworks Announces Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced its participation in the...

May 03, 2023, 07:00 ET Ginkgo Bioworks Announces Date of First Quarter 2023 Results Presentation

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a...

Apr 24, 2023, 07:00 ET Visolis and Ginkgo Bioworks Announce Partnership to Improve Microbial Strain for Bio-Isoprene and Sustainable Aviation Fuel Production

Visolis, a company combining advanced bioengineering with chemical catalysis to provide sustainable, carbon-negative materials, today announced a...

Apr 19, 2023, 07:00 ET Ginkgo Bioworks Previews Today's Annual Ferment Conference

Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its annual conference,...

Apr 17, 2023, 07:00 ET Ginkgo Bioworks and Syngenta Seeds Announce Collaboration to Develop New Traits for the Next Generation of Seed Technology

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and Syngenta Seeds ("Syngenta"), one of the ...

Apr 14, 2023, 07:00 ET Ginkgo Bioworks and the Government of the Democratic Republic of the Congo Announce Plans to Develop and Implement New Biosecurity Capabilities in the Region

Ginkgo Bioworks (NYSE: DNA), which is building the leading horizontal platform for cell programming and biosecurity, and the Institut National de la...

Apr 13, 2023, 07:00 ET Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies

The Wisconsin Alumni Research Foundation (WARF), which has a mission of supporting research at the University of Wisconsin-Madison, and Ginkgo...

Apr 12, 2023, 07:00 ET Ginkgo Bioworks to Host Annual Ferment Conference

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its annual conference, Ferment,...

Apr 05, 2023, 07:00 ET Ginkgo Bioworks Strengthens End-to-End R&D Capabilities in Gene Therapy through Acquisition of StrideBio's AAV Capsid Discovery and Engineering Platform Assets

Platform includes large library of existing capsids, which have been optimized for performance and targeting across a range of application areas...

Apr 04, 2023, 07:00 ET Solvay Announces Strategic Collaboration With Ginkgo Bioworks And Expands Its R&I Footprint In The United States

Solvay, a leading science and materials company whose technologies bring benefits to many aspects of daily life, today announced a strategic...

Mar 02, 2023, 07:00 ET Ginkgo Bioworks Announces Participation in Cowen's 43rd Annual Health Care Conference

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced today that Co-Founder and CEO...

Mar 01, 2023, 16:01 ET Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced...

Feb 22, 2023, 07:00 ET Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2022 Results Presentation

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a...

Feb 16, 2023, 07:00 ET Zymtronix and Ginkgo Bioworks Announce Partnership to Produce Enzymes for the Industrialization of Cell-Free Biomanufacturing

Zymtronix, a developer of cell-free process technologies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell...

Feb 15, 2023, 07:00 ET Ginkgo Bioworks Announces Pathogen Monitoring Program at Kigali International Airport

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Rwanda Biomedical Centre (RBC)...

Feb 06, 2023, 04:00 ET Bioweg and Ginkgo Bioworks Announce Partnership to Develop Cost Effective and Efficacious Bio-Based Materials to Reduce the Use of Microplastic Pollutants

Bioweg, a producer of highly functional and customizable bio-based materials, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform ...

Jan 18, 2023, 07:00 ET NAMUH and Ginkgo Bioworks Announce Partnership to Produce Multiple Infant Nutrition Products

NAMUH, an infant nutrition company, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity,...

Jan 17, 2023, 07:00 ET Ginkgo Bioworks and the Public Health Center of the Ukraine Ministry of Health Announce Collaboration to Implement Biosecurity Capabilities in Ukraine

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Public Health Center of the Ukraine ...

Jan 17, 2023, 07:00 ET Ginkgo Bioworks and XpresCheck Expand CDC's Traveler-Based Genomic Surveillance Program to Detect Influenza Variants

Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc. (Nasdaq: XWEL) today announced that they have expanded their support for the Centers for Disease Control...

Jan 11, 2023, 07:00 ET Ginkgo Bioworks Provides Preliminary Unaudited 2022 Revenue Highlights and Business Review

Expects to meet 2022 guidance ranges for Total revenue and new Cell Programs Year end cash balance of approximately $1.3 billion provides ample...